Table 2.

The miRNAs correlated with lung function in IPF PBMCs

miRNA	DLCO		FVC
	ρ*	PDLCO_miRNA	ρ*	PFVC_miRNA
hsa-miR-125b-1†	−0.41	0.037	−0.49	0.009
hsa-miR-1275	−0.55	0.003	−0.49	0.009
hsa-miR-144	−0.45	0.022	−0.59	0.001
hsa-miR-150	0.52	0.006	0.42	0.028
hsa-miR-196a†	0.58	0.002	0.42	0.030
hsa-miR-223	−0.45	0.021	−0.43	0.024
hsa-miR-31	0.44	0.024	0.41	0.032
hsa-miR-342-3p	0.53	0.005	0.47	0.014
hsa-miR-342-5p	0.59	0.002	0.47	0.014
hsa-miR-548e	0.53	0.006	0.44	0.022
hsa-miR-636	0.50	0.010	0.46	0.016
hsa-miR-891a	0.53	0.006	0.47	0.012

DLCO, lung diffusing capacity; FVC, forced vital capacity; IPF, idiopathic pulmonary fibrosis; PBMC, peripheral blood mononuclear cell.

^*Spearman’s rank correlation coefficient between miRNA expression level and DLCO/FVC

^†The miRNA originates from the opposite arm of the precursor